Home » Psychology news » Cancer drug restores brain dopamine, reduces toxic proteins in Parkinson, dementia
Cancer drug restores brain dopamine, reduces toxic proteins in Parkinson, dementia
July 12, 2016 by NewsBot
A small phase I study provides molecular evidence that an FDA-approved drug for leukemia significantly increased brain dopamine and reduced toxic proteins linked to disease progression in patients with Parkinson’s disease or dementia with Lewy bodies.
